266 related articles for article (PubMed ID: 30442288)
1. Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.
Ochoa JP; Sabater-Molina M; García-Pinilla JM; Mogensen J; Restrepo-Córdoba A; Palomino-Doza J; Villacorta E; Martinez-Moreno M; Ramos-Maqueda J; Zorio E; Peña-Peña ML; García-Granja PE; Rodríguez-Palomares JF; Cárdenas-Reyes IJ; de la Torre-Carpente MM; Bautista-Pavés A; Akhtar MM; Cicerchia MN; Bilbao-Quesada R; Mogollón-Jimenez MV; Salazar-Mendiguchía J; Mesa Latorre JM; Arnaez B; Olavarri-Miguel I; Fuentes-Cañamero ME; Lamounier A; Pérez Ruiz JM; Climent-Payá V; Pérez-Sanchez I; Trujillo-Quintero JP; Lopes LR; Repáraz-Andrade A; Marín-Iglesias R; Rodriguez-Vilela A; Sandín-Fuentes M; Garrote JA; Cortel-Fuster A; Lopez-Garrido M; Fontalba-Romero A; Ripoll-Vera T; Llano-Rivas I; Fernandez-Fernandez X; Isidoro-García M; Garcia-Giustiniani D; Barriales-Villa R; Ortiz-Genga M; García-Pavía P; Elliott PM; Gimeno JR; Monserrat L
J Am Coll Cardiol; 2018 Nov; 72(20):2457-2467. PubMed ID: 30442288
[TBL] [Abstract][Full Text] [Related]
2. Variant Spectrum of Formin Homology 2 Domain-Containing 3 Gene in Chinese Patients With Hypertrophic Cardiomyopathy.
Wu G; Ruan J; Liu J; Zhang C; Kang L; Wang J; Zou Y; Song L
J Am Heart Assoc; 2021 Feb; 10(5):e018236. PubMed ID: 33586461
[TBL] [Abstract][Full Text] [Related]
3. Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.
Wooten EC; Hebl VB; Wolf MJ; Greytak SR; Orr NM; Draper I; Calvino JE; Kapur NK; Maron MS; Kullo IJ; Ommen SR; Bos JM; Ackerman MJ; Huggins GS
Circ Cardiovasc Genet; 2013 Feb; 6(1):10-8. PubMed ID: 23255317
[TBL] [Abstract][Full Text] [Related]
4. Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathy.
Ochoa JP; Lopes LR; Perez-Barbeito M; Cazón-Varela L; de la Torre-Carpente MM; Sonicheva-Paterson N; De Uña-Iglesias D; Quinn E; Kuzmina-Krutetskaya S; Garrote JA; Elliott PM; Monserrat L
Clin Genet; 2020 Jul; 98(1):86-90. PubMed ID: 32335906
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family with hypertrophic cardiomyopathy.
Huang S; Pu T; Wei W; Xu R; Wu Y
J Gene Med; 2020 Mar; 22(3):e3146. PubMed ID: 31742804
[TBL] [Abstract][Full Text] [Related]
6. Intermediate-effect size p.Arg637Gln in
Piqueras-Flores J; Villacorta-Argüelles E; Galvin J; Climent-Payá V; Escobar-López LE; Amor-Salamanca A; Garcia-Hernandez S; Esmonde S; Martínez-Del Río J; Soto-Pérez M; Garcia-Pavia P; Ochoa JP
J Med Genet; 2024 Apr; 61(5):423-427. PubMed ID: 38160043
[TBL] [Abstract][Full Text] [Related]
7. A novel splice-site FHOD3 founder variant is a common cause of hypertrophic cardiomyopathy in the population of the Balkans-A cohort study.
Vodnjov N; Toplišek J; Maver A; Čuturilo G; Jaklič H; Teran N; Višnjar T; Škrjanec Pušenjak M; Hodžić A; Miljanović O; Peterlin B; Writzl K
PLoS One; 2023; 18(12):e0294969. PubMed ID: 38051749
[TBL] [Abstract][Full Text] [Related]
8. Interaction between cardiac myosin-binding protein C and formin Fhod3.
Matsuyama S; Kage Y; Fujimoto N; Ushijima T; Tsuruda T; Kitamura K; Shiose A; Asada Y; Sumimoto H; Takeya R
Proc Natl Acad Sci U S A; 2018 May; 115(19):E4386-E4395. PubMed ID: 29686099
[TBL] [Abstract][Full Text] [Related]
9. Mutations in
Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
[TBL] [Abstract][Full Text] [Related]
11. Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing.
Burns C; Bagnall RD; Lam L; Semsarian C; Ingles J
Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28790153
[TBL] [Abstract][Full Text] [Related]
12. Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment.
Das K J; Ingles J; Bagnall RD; Semsarian C
Genet Med; 2014 Apr; 16(4):286-93. PubMed ID: 24113344
[TBL] [Abstract][Full Text] [Related]
13. NEXN Gene in Cardiomyopathies and Sudden Cardiac Deaths: Prevalence, Phenotypic Expression, and Prognosis.
Hermida A; Ader F; Millat G; Jedraszak G; Maury P; Cador R; Catalan PA; Clerici G; Combes N; De Groote P; Dupin-Deguine D; Eschalier R; Faivre L; Garcia P; Guillon B; Janin A; Kugener B; Lackmy M; Laredo M; Le Guillou X; Lesaffre F; Lucron H; Milhem A; Nadeau G; Nguyen K; Palmyre A; Perdreau E; Picard F; Rebotier N; Richard P; Rooryck C; Seitz J; Verloes A; Vernier A; Winum P; Yabeta GA; Bouchot O; Chevalier P; Charron P; Gandjbakhch E
Circ Genom Precis Med; 2024 Feb; 17(1):e004285. PubMed ID: 38059363
[TBL] [Abstract][Full Text] [Related]
14. Glycogen storage diseases presenting as hypertrophic cardiomyopathy.
Arad M; Maron BJ; Gorham JM; Johnson WH; Saul JP; Perez-Atayde AR; Spirito P; Wright GB; Kanter RJ; Seidman CE; Seidman JG
N Engl J Med; 2005 Jan; 352(4):362-72. PubMed ID: 15673802
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
Pasquale F; Syrris P; Kaski JP; Mogensen J; McKenna WJ; Elliott P
Circ Cardiovasc Genet; 2012 Feb; 5(1):10-7. PubMed ID: 22144547
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy - An ancillary study of the Portuguese registry of hypertrophic cardiomyopathy.
Lopes LR; Brito D; Belo A; Cardim N;
Int J Cardiol; 2019 Mar; 278():173-179. PubMed ID: 30554928
[TBL] [Abstract][Full Text] [Related]
17. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications.
Ingles J; Burns C; Bagnall RD; Lam L; Yeates L; Sarina T; Puranik R; Briffa T; Atherton JJ; Driscoll T; Semsarian C
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408708
[TBL] [Abstract][Full Text] [Related]
18. The actin-organizing formin protein Fhod3 is required for postnatal development and functional maintenance of the adult heart in mice.
Ushijima T; Fujimoto N; Matsuyama S; Kan-O M; Kiyonari H; Shioi G; Kage Y; Yamasaki S; Takeya R; Sumimoto H
J Biol Chem; 2018 Jan; 293(1):148-162. PubMed ID: 29158260
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characterization of patients with hypertrophic cardiomyopathy and right atrial enlargement.
Limongelli G; Masarone D; Frisso G; Iacomino M; Ferrara I; Rea A; Gravino R; Bossone E; Salvatore F; Calabro R; Elliott P; Pacileo G
J Cardiovasc Med (Hagerstown); 2017 Apr; 18(4):249-254. PubMed ID: 26808413
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
Posen BM; Moolman JC; Corfield VA; Brink PA
Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
